Compounds > cepharanthine
Page last updated: 2024-08-21

cepharanthine and paclitaxel

cepharanthine has been researched along with paclitaxel in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1
Akiyama, S; Ashby, CR; Chen, X; Chen, ZS; Furukawa, T; Hopper-Borge, E; Huang, XC; Kruh, GD; Kuang, YH; Peng, XX; Shen, T; Shi, Z; Zhou, Y1
Huang, CZ; Jiang, JH; Liu, YX; Ma, F; Peng, YM; Wang, QD; Wang, YF; Zhang, Y1

Other Studies

3 other study(ies) available for cepharanthine and paclitaxel

ArticleYear
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012
Cepharanthine is a potent reversal agent for MRP7(ABCC10)-mediated multidrug resistance.
    Biochemical pharmacology, 2009, Mar-15, Volume: 77, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Biological Transport, Active; Cell Line; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Humans; Multidrug Resistance-Associated Proteins; Paclitaxel

2009
Cepharanthine hydrochloride reverses P‑glycoprotein-mediated multidrug resistance in human ovarian carcinoma A2780/Taxol cells by inhibiting the PI3K/Akt signaling pathway.
    Oncology reports, 2017, Volume: 38, Issue:4

    Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Carcinoma; Cell Line, Tumor; Chromones; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Morpholines; Oncogene Protein v-akt; Ovarian Neoplasms; Paclitaxel; Phosphatidylinositol 3-Kinases; Signal Transduction

2017